Further research in these areas is of great importance because Lp-PLA2 and SOD are modifiable risk factors and, if further confirmed, may be considered as therapeutic targets for preventing cognitive impairment development in CSVD and reducing its severity. The gene discussed is PLA2G7; the disease is Cognitive impairment.